PTSM: Pharmaceutical Technology Sourcing and Management
The CordenPharma Chenôve, France manufacturing facility completed an FDA Inspection with no 483s reported.
CordenPharma announced on Aug. 31, 2016 that the CordenPharma Chenôve (France) manufacturing facility completed an FDA Inspection and received a successful response with no 483s reported. The previous FDA Inspection took place in 2014.
Yves Michon, Managing Director of CordenPharma Chenôve comments, “We are pleased with the outcome of the FDA Inspection in August 2016, as it reflects our willingness to comply with the highest level of cGMP regulatory compliance while continuously improving our standards for our customers and their projects going forward.”
Source: CordenPharma
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.